FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF CHRONOTHERAPEUTIC DRUG DELIVERY OF ROSUVASTATIN BY COMPRESSED COATED TECHNIQUE

Journal Title: Int J of Pharm Rev& Res - Year 2015, Vol 5, Issue 3

Abstract

Rosuvastatin is an HMG –COA reductase inhibitor, primarily used for the treatment of hyper cholestremia associated with cardiovascular diseases. It belongs to BCS class II having a half-life of 19 hrs and 20% bioavailability. The purpose of the present work was to develop a press-coated, chronotherapeutic drug delivery system. The core tablet was formulated using the super-disintegrants and croscarmellose sodium. A press-coated tablet contained the polymers ethyl cellulose, eudragit L 100 &S 100. The tablets were evaluated for physical characteristics are pre and post compression parameters, lag time, FTIR, DSC, and in vitro the 10% superdisintgrant showed good results. The FTIR and DSC study predicted no chemical interactions between the drug and excipients. The lag time for the tablet coated with 100 mg ethyl cellulose was 9±0.1 hrs with90±1.5% drug release; with 100 mg eudragit L100, the lag time was 6±0.1 hrs with 89.71±1.2% drug release; and with 100 mg eudragit S100, the lag time was6±0.2 hrs with 88±1.7% drug release. The release mechanism of the tablet followed the Korsmeyer-Peppas equation and a first-order release pattern& lag time behavior have shown good in vitro release

Authors and Affiliations

Gatla Narasimha Reddy1 , B. Arunkumar2 , Ramavath Naresh Naik2

Keywords

Related Articles

ANTI-INFLAMMATORY ACTIVITY OF THE FRACTIONS OF THE AQUEOUS EXTRACT OF Ximenia americana (LINNAEUS)

This study is a continuation of previous work during which we studied the effects of aqueous extract of Ximenia americana on inflammation induced by carrageenan on the rat paw. These studies have demonstrated the anti in...

FORMULATION AND EVALUATION OF ZOLPIDEM TARTRATE SUBLINGUAL TABLETS

In the present study 3.5 mg strength will be going to be prepared and also evaluated for all the physical parameters evaluation and in-vitro drug dissolution studies. The first strategy was developed based on innovator c...

DIETARY PHYTOCHEMICALS AS PROMISING PREVENTIVE MEASURES FOR SKIN CANCER

Currently, skin cancer occurs at a rate of one in every six Americans (18%), and constitutes more than 30% of all newly diagnosed cancer patients in the world [1, 2]. In skin, UV radiation-induced gene mutations have bee...

FORMULATION AND EVALUATIONOF ITRACONAZOLE ETHOSOMAL GEL

Optimization of drug delivery through human skin is important in modern therapy. Recently, the transdermal route vied with oral treatment as the most successful innovative research area in drug delivery. The aim of prese...

IN VITRO STUDY ON THROMBOLYTIC ACTIVITY OF HYDROALCOHOLIC EXTRACT OF VALERIANA JATAMANSI AND ORIGANUM VULGARE LEAVES

The present study was investigated to find out the thrombolytic activity of hydroalcoholic extract of Valeriana Jatamansi and Origanum Vulgare leaves by using in vitro method along with streptokinase as a standard. The s...

Download PDF file
  • EP ID EP138299
  • DOI -
  • Views 104
  • Downloads 0

How To Cite

Gatla Narasimha Reddy1, B. Arunkumar2, Ramavath Naresh Naik2 (2015). FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF CHRONOTHERAPEUTIC DRUG DELIVERY OF ROSUVASTATIN BY COMPRESSED COATED TECHNIQUE. Int J of Pharm Rev& Res, 5(3), 299-304. https://europub.co.uk./articles/-A-138299